Monitor the full Q1 earnings report in May for updated guidance and margin trends; despite flat sentiment, any upward revision in outlook could trigger a positive stock reaction given recent underperformance.
Price Chart
Executive Summary
Sanuwave Health reported preliminary Q1 2026 revenue of $9.6–9.7 million, up 3–4% year-over-year and in line with prior guidance. The company noted market uncertainty due to reimbursement changes in wound care, but strong engagement at recent conferences signals growing interest in its Ultramist technology.
Key Financial Metrics
Key Facts
- Preliminary Q1 2026 revenue: $9.6–9.7 million
- 3–4% year-over-year growth from Q1 2025
- In line with guidance provided in Q4 2025 earnings release
- No EPS or profitability data disclosed in this release
- Market dynamics affected by reimbursement changes for skin substitutes and allografts
Financial Impact
Revenue increase of $0.28M–$0.38M YoY based on midpoint
Risk Factors
- Reimbursement headwinds in advanced wound care may persist
- Preliminary revenue near lower end of guidance range suggests demand softness
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3275860 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 8-K | $4.65 $4.70 | ▼ −1.08% | ▲ +0.13% | $5.13 (−10.32%) |
Aug 6, 2026 11w ago | 8-K | $5.88 $4.74 | ▲ +19.39% | ▲ +19.79% | $5.13 (+12.76%) |
Aug 6, 2026 11w ago | Press Release | $5.88 $4.74 | ▲ +19.39% | ▲ +19.79% | $5.13 (+12.76%) |
Jul 30, 2026 12w ago | Press Release | $6.17 $5.88 | ▼ −4.70% | ▼ −8.21% | $5.13 (−16.86%) |
Jun 16, 2026 19w ago | 8-K | $8.51 $8.20 | ▲ +3.64% | ▲ +1.41% | $5.13 (+39.72%) |
Jun 16, 2026 19w ago | Press Release | $8.51 $8.20 | ▲ +3.64% | ▲ +1.41% | $5.13 (+39.72%) |
Jun 11, 2026 19w ago | Institutional Cluster | $14.69 $9.09 | ▼ −38.12% | ▼ −38.55% | $5.13 (−65.08%) |
May 12, 2026 23w ago | Press Release | $18.94 $16.69 | ▼ −11.88% | ▼ −10.72% | $5.13 (−72.91%) |
May 6, 2026 24w ago | Press Release | $16.65 $18.94 | ▲ +13.75% | ▲ +12.25% | $5.13 (−69.19%) |
Apr 16, 2026 27w ago | 8-K | $20.61 $18.70 | ▼ −9.27% | ▼ −9.82% | $5.13 (−75.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers